Skip to main content
MarketStoryBook

LFMD in “GLP-1 Eats Everything”

LifeMD, Inc.

Bull sideFadingExposure: not rated yet

LifeMD can monetize growing GLP-1 demand through its direct-to-consumer telehealth weight-management platform and recurring clinical services.

LFMD impact map — “GLP-1 Eats Everything”

How this story travels from the headline to LFMD’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.

Loading LFMD impact map…

Price history, marked with story events

Oct 1, 2025 – Oct 2, 2026 · 231 sessions

Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions

Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…

Full story

GLP-1 Eats Everything

Appetite suppression as a macro variable.

BULL side — LifeMD can monetize growing GLP-1 demand through its direct-to-consumer telehealth weight-management platform and recurring clinical services.

Read the full GLP-1 Eats Everything story